{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:11:59Z","timestamp":1772752319996,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.antiviral.2012.12.013","type":"journal-article","created":{"date-parts":[[2012,12,23]],"date-time":"2012-12-23T15:18:32Z","timestamp":1356275912000},"page":"240-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir"],"prefix":"10.1016","volume":"97","author":[{"given":"Dayan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Sleeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marnie","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minju","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander I.","family":"Klimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa V.","family":"Gubareva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuelong","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2012.12.013_b0010","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1128\/JCM.05069-11","article-title":"Detection of an influenza B virus strain with reduced susceptibility to neuraminidase inhibitor drugs","volume":"49","author":"Bastien","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2012.12.013_b0015","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/508777","article-title":"Characterization of multidrug-resistant influenza A\/H3N2 viruses shed during 1 year by an immunocompromised child","volume":"43","author":"Baz","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.12.013_b0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcv.2007.10.019","article-title":"Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors","volume":"41","author":"Escuret","year":"2008","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2012.12.013_b0025","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/314440","article-title":"Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus","volume":"178","author":"Gubareva","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.12.013_b0030","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/jama.297.13.1435","article-title":"Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors","volume":"297","author":"Hatakeyama","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2012.12.013_b0045","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.50.5.1872-1874.2006","article-title":"Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient","volume":"50","author":"Hurt","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.12.013_b0040","doi-asserted-by":"crossref","unstructured":"Hurt, A.C., Holien, J.K., Barr, I.G., 2009. In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses. Antimicrob. Agents Chemother. 53, 4433\u20134440.","DOI":"10.1128\/AAC.00334-09"},{"key":"10.1016\/j.antiviral.2012.12.013_b0035","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1056\/NEJMc1111078","article-title":"Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza","volume":"365","author":"Hurt","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2012.12.013_b0005","unstructured":"Influenza-associated pediatric deaths, 2011, United States, September 2010\u2013August 2011. MMWR Morb. Mortal. Wkly. Rep. 60:1233\u20131238. doi:mm6036a1 [pii]."},{"key":"10.1016\/j.antiviral.2012.12.013_b0050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/500465","article-title":"Recovery of drug-resistant influenza virus from immunocompromised patients: a case series","volume":"193","author":"Ison","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.12.013_b0125","doi-asserted-by":"crossref","unstructured":"Lackenby, A., G. J. Moran, R. Pebody, S. Miah, L. Calatayud, S. Bolotin, I. Vipond, P. Muir, M. Guiver, J. McMenamin, A. Reynolds, C. Moore, R. Gunson, C. Thompson, M. Galiano, A. Bermingham, J. Ellis, and M. Zambon. 2011. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010\/11. Euro. Surveill 16, 19784 [pii].","DOI":"10.2807\/ese.16.05.19784-en"},{"key":"10.1016\/j.antiviral.2012.12.013_b0060","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3201\/eid1504.181280","article-title":"Oseltamivir-resistant influenza virus A (H1N1) Europe 2007\u201308 Season","volume":"15","author":"Meijer","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.12.013_b0065","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.01339-05","article-title":"Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use","volume":"50","author":"Monto","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.12.013_b0075","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1086\/656439","article-title":"Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y\/I223R mutation from a child after prolonged treatment with oseltamivir","volume":"51","author":"Nguyen","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.12.013_b0080","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1128\/AAC.00581-10","article-title":"Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays","volume":"54","author":"Nguyen","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.12.013_b0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3851\/IMP2067","article-title":"Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods","volume":"17","author":"Nguyen","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2012.12.013_b0085","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.3390\/v2102269","article-title":"Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective","volume":"2","author":"Okomo-Adhiambo","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2012.12.013_b0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1620\/tjem.214.113","article-title":"Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City","volume":"214","author":"Sato","year":"2008","journal-title":"Japan. Tohoku J. Exp. Med."},{"key":"10.1016\/j.antiviral.2012.12.013_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2002.1719","article-title":"Reappearance and global spread of variants of influenza B\/Victoria\/2\/87 lineage viruses in the 2000\u20132001 and 2001\u20132002 seasons","volume":"303","author":"Shaw","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.12.013_b0100","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.00555-08","article-title":"Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008","volume":"52","author":"Sheu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.12.013_b0105","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3201\/eid1711.110787","article-title":"Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010\u201311","volume":"17","author":"Sleeman","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.12.013_b0110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3201\/eid1802.111466","article-title":"Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010\u201311","volume":"18","author":"Storms","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.12.013_b0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/509925","article-title":"Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children","volume":"44","author":"Sugaya","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.12.013_b0120","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1003749","article-title":"Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus","volume":"363","author":"Van","year":"2010","journal-title":"N. Engl. J. Med."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212002938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212002938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T15:23:38Z","timestamp":1643988218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354212002938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0166354212002938"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.12.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}